Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:12 pm Purchase | 2021-12-31 | 13G | Affimed N.V. AFMD | Ridgeback Capital Investments L.P. | 772,211 6.500% | 127,211 (+19.72%) | Filing History |
| 2021-04-14 11:25 am Purchase | 2021-04-09 | 13G | Affimed N.V. AFMD | Ridgeback Capital Investments L.P. | 645,000 5.500% | 645,000 (New Position) | Filing History |
| 2021-04-09 4:54 pm Purchase | 2021-03-30 | 13G | F-star Therapeutics, Inc. FSTX | Ridgeback Capital Investments L.P. | 494,360 5.400% | 86,793 (+21.30%) | Filing History |
| 2021-02-16 4:23 pm Sale | 2020-12-31 | 13G | Verastem, Inc. VSTM | Ridgeback Capital Investments L.P. | 0 0.000% | -839,020 (Position Closed) | Filing History |
| 2021-02-16 4:22 pm Sale | 2020-12-31 | 13G | Sutro Biopharma, Inc. STRO | Ridgeback Capital Investments L.P. | 114,498 2.500% | -86,971 (-43.17%) | Filing History |
| 2021-02-16 4:21 pm Sale | 2020-12-31 | 13G | Myomo, Inc. MYO | Ridgeback Capital Investments L.P. | 104,755 2.300% | -35,245 (-25.18%) | Filing History |
| 2021-02-16 4:20 pm Purchase | 2020-12-31 | 13G | F-star Therapeutics, Inc. FSTX | Ridgeback Capital Investments L.P. | 407,567 4.500% | 407,567 (New Position) | Filing History |
| 2021-02-16 4:19 pm Purchase | 2020-12-31 | 13G | Cogent Biosciences, Inc. COGT | Ridgeback Capital Investments L.P. | 1,252,250 5.200% | 1,252,250 (New Position) | Filing History |
| 2021-02-16 4:18 pm Sale | 2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Ridgeback Capital Investments L.P. | 1,100,000 4.200% | -338,487 (-23.53%) | Filing History |
| 2021-02-16 4:17 pm Purchase | 2020-12-31 | 13G | Bicycle Therapeutics plc BCYC | Ridgeback Capital Investments L.P. | 1,861,833 8.700% | 717,200 (+62.66%) | Filing History |